Damon Runyon Researchers

Meet Our Scientists
Costas A. Lyssiotis, PhD

Dr. Lyssiotis focuses on how oncogenes affect cellular metabolism in pancreatic cancer. In particular, he is interested in understanding how mutations in the oncogene Kras alter cellular metabolism in pancreatic ductal adenocarcinoma to facilitate cell growth. He will determine if distinct components of Kras-mediated signaling can be targeted for therapeutic gain. Ultimately, this work aims to translate our understanding of pancreatic cancer cell metabolism into therapies for this devastating disease. 

Project title: "Exploring the metabolic effects of oncogenic Kras in pancreatic ductual adenocarcinoma"
Institution: University of Michigan
Award Program: Dale Frey Scientist
Cancer Type: Pancreatic
Research Area: Biochemistry